News Image

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC

Provided By GlobeNewswire

Last update: Jun 17, 2025

– Veteran executive with over 20 years of oncology leadership and clinical experience with proven track record of success in bringing development candidates through late-stage clinical development –

Read more at globenewswire.com

CARDIFF ONCOLOGY INC

NASDAQ:CRDF (11/21/2025, 8:20:52 PM)

After market: 2.03 0 (0%)

2.03

+0.07 (+3.57%)



Find more stocks in the Stock Screener

Follow ChartMill for more